Compare CURX & ATON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CURX | ATON |
|---|---|---|
| Founded | 2018 | 1973 |
| Country | United States | British Virgin Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 6.8M |
| IPO Year | 2025 | N/A |
| Metric | CURX | ATON |
|---|---|---|
| Price | $0.39 | $0.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | ★ 5.5M | 539.3K |
| Earning Date | 09-09-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.26 | $0.35 |
| 52 Week High | $9.18 | $13.80 |
| Indicator | CURX | ATON |
|---|---|---|
| Relative Strength Index (RSI) | 54.41 | 35.87 |
| Support Level | $0.39 | $0.36 |
| Resistance Level | $0.42 | $3.30 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 29.85 | 10.53 |
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.